Pharma
R&D Pipeline

Image
 

Hybrigenics unveils final results of inecalcitol phase IIa clinical study
Hybrigenics determines the maximum dosage of inecalcitol
 

Hybrigenics and Servier enter into a licence and research collaboration agreement in oncology and other therapeutic fields  

Hybrigenics Pharma News:

Hybrigenics unveils final results of inecalcitol Phase IIa clinical study

 
Hybrigenics unveils a lead chemical structure for its discovery of new anticancer drugs
© 2012 hybrigenics